Frank D. Lee

CIK 1814686 · Chief Executive Officer · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.67M

Companies

4

Total Filings

22

Lifetime Open-Market Net

-$330.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BHC Director 95,210 $5.06 $481.8K -$254.7K 5 2026-05-26
PCRX Chief Executive Officer 660,830 $22.99 $15.19M $100.0K 7 2026-02-13
BOLT Director $4.56 $0 5 2024-06-14
Forma Therapeutics Holdings, Inc. (FMTX) Delisted President and CEO 0 $20.01 $0 -$175.8K 5 2022-10-14

Recent Filings · Page 2 of 3

22 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-14 BOLT Grant (A) $0 EDGAR
2024-05-21 BHC Grant (A) +35,360 $0 EDGAR
2024-01-04 PCRX Grant (A) +99,520 $0 EDGAR
2023-06-14 BOLT Grant (A) $0 EDGAR
2022-10-14 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Mixed −201,436 $0 EDGAR
2022-06-10 BOLT Grant (A) $0 EDGAR
2022-03-28 BOLT Grant (A) $0 EDGAR
2022-03-02 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Grant (A) +121,667 $0 EDGAR
2022-02-25 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Sell (S) −17,981 -$175.8K EDGAR
2021-11-19 BOLT Grant (A) $0 EDGAR
Showing 1120 of 22
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.